Medication to reduce alcohol cravings
Pro Research Analysisby 
Searched over 200M research papers
Medications to Reduce Alcohol Cravings
Gabapentin for Alcohol Craving Reduction
Gabapentin has shown promise in reducing alcohol consumption and cravings. In a randomized, double-blind, placebo-controlled trial, 60 male alcohol-dependent subjects were treated with gabapentin (300 mg twice daily) for 28 days. The results indicated a significant reduction in the number of drinks per day and the percentage of heavy drinking days, along with an increase in the percentage of days of abstinence compared to the placebo group. Additionally, gabapentin was associated with a more pronounced decrease in obsessive-compulsive symptoms related to drinking1.
Naltrexone and Oxytocin Combination
Naltrexone, an opioid antagonist, is another medication that has been effective in reducing alcohol cravings. A study involving 18 alcohol-dependent volunteers found that naltrexone treatment resulted in higher cortisol levels and lower levels of craving compared to placebo. Participants treated with naltrexone drank fewer drinks and reported lower levels of alcohol craving during a self-administration experiment4. Furthermore, a phase II trial is investigating the combined effects of naltrexone and oxytocin on stress-induced and alcohol cue-induced cravings, suggesting potential synergistic benefits2.
Ondansetron and Naltrexone Synergy
The combination of ondansetron, a 5-HT3 antagonist, and naltrexone has shown preliminary evidence of reducing cravings among early onset alcoholics. In an 8-week double-blind placebo-controlled clinical trial, participants receiving the combination treatment had significantly lower scores on measures of "automaticity of drinking" and "alcohol consumption" compared to the placebo group. This combination appears to counteract the interaction between central 5-HT3 receptors and the endogenous opioid system, reducing the salience and intensity of drinking5.
Extended-Release Naltrexone (XR-NTX)
Extended-release naltrexone (XR-NTX) has also been effective in reducing alcohol cravings and use behaviors. In a study involving 337 patients, cravings decreased significantly after the first dose of XR-NTX, and the majority of patients reported no alcohol use at follow-up assessments. This suggests that XR-NTX can maintain its efficacy in reducing cravings and promoting abstinence over an extended period6.
Baclofen's Role in Reducing Cravings
Baclofen, a GABA(B) receptor agonist, has shown efficacy in reducing alcohol cravings and intake. In a preliminary study, baclofen administration led to a significant reduction in craving levels and maintained abstinence in the majority of participants. Another double-blind, placebo-controlled study confirmed these findings, showing that baclofen was effective in inducing and maintaining abstinence and reducing the obsessive and compulsive components of craving7 8.
Other Pharmacological Approaches
Other medications such as acamprosate and anticonvulsants like topiramate have also been studied for their effects on alcohol cravings. These medications have shown good results in promoting abstinence and reducing cravings, making them viable options for treating alcohol use disorders9. Additionally, the use of anticraving medications in combination, such as naltrexone plus acamprosate, may enhance their effectiveness10.
Conclusion
Various medications, including gabapentin, naltrexone, ondansetron, baclofen, and others, have demonstrated efficacy in reducing alcohol cravings and consumption. These pharmacological treatments offer promising options for individuals struggling with alcohol dependence, potentially improving their chances of maintaining abstinence and reducing relapse rates. Further research and larger-scale studies are needed to optimize these treatments and explore their combined effects.
Sources and full results
Most relevant research papers on this topic
Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
Gabapentin effectively reduces alcohol consumption and cravings, potentially aiding patients in maintaining abstinence and supporting its potential use in alcohol withdrawal and dependence treatment.
RCT
Highly CitedON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder–Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial
Oxytocin combined with naltrexone may reduce alcohol cravings and stress reactivity in alcohol use disorder patients.
RCT
Rigorous JournalPharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders
Pharmacological approaches to reduce craving in alcohol use disorders have mixed results, with some medications showing promising results but others showing inconsistent results.
Literature ReviewRigorous JournalHighly CitedNaltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis
Naltrexone reduces alcohol cravings and consumption in alcohol-dependent individuals, potentially due to its ability to activate the hypothalamo-pituitary-adrenocortical axis.
RCTHighly CitedCombining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence
The combination of ondansetron and naltrexone effectively reduces cravings and alcohol consumption in early onset alcoholics, potentially decreasing drinking salience and intensity.
RCTHighly CitedEffectiveness of extended release naltrexone to reduce alcohol cravings and use behaviors during treatment and at follow-up.
Extended-release naltrexone (XR-NTX) effectively reduces alcohol cravings and use behaviors during treatment and at 30- and 60-day follow-ups.
Non-RCT
Large Human TrialAbility of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
Baclofen may help reduce alcohol intake and cravings in alcoholic individuals, suggesting a potential role in treating alcohol problems.
Non-RCTHighly CitedBaclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
Baclofen effectively induces abstinence and reduces alcohol craving and consumption in alcohol-dependent patients, warranting further investigation.
RCTHighly CitedPharmacological Treatment of Alcohol Cravings
Naltrexone and Acamprosate are the gold standard for relieving alcohol cravings and promoting abstinence, while anticonvulsants and Baclofen show good results as second-line medications.
Literature Review